These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7025162)

  • 41. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of post-transfusion hepatitis. Role of sensitive hepatitis B antigen screening tests, source of blood and volume of transfusion.
    Koretz RL; Gitnick GL
    Am J Med; 1975 Dec; 59(6):754-60. PubMed ID: 1190252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative evaluation of 5 third-generation methods for the detection of HBsAg].
    Dentico P; Baldi L; Trotta F; Buongiorno R; Pastore G; Schiraldi O
    Quad Sclavo Diagn; 1982 Sep; 18(3):361-7. PubMed ID: 7184049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme-linked immunosorbent assay for hepatitis B surface antigen.
    Wolters G; Kuijpers LP; Kacaki J; Schuurs AH
    J Infect Dis; 1977 Oct; 136 Suppl():S311-7. PubMed ID: 908857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of viral hepatitis marker test methods based on AABB-CAP survey data.
    Polesky HF; Hanson MR
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):521-4. PubMed ID: 7282638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sensitivity and specificity of 2 methods of determining surface antigen (HBsAg) in various forms of hepatitis B pathology].
    Dentico P; Baldi L; Trotta F; Buongiorno R; Pastore G; Schiraldi O
    Quad Sclavo Diagn; 1981 Dec; 17(4):543-52. PubMed ID: 7347832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Latex agglutination test for detection of Australia antigen (HB-Ag) among blood donors and patients.
    Hopkins R; Das PC
    J Clin Pathol; 1974 Jan; 27(1):40-4. PubMed ID: 4856589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation and limits of different techniques for the determination of HBsAg (author's transl)].
    Fanetti G; Ferrini C
    Quad Sclavo Diagn; 1980 Mar; 16(1):94-9. PubMed ID: 7244090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen.
    Wolters G; Kuijpers L; Kacaki J; Schuurs A
    J Clin Pathol; 1976 Oct; 29(10):873-9. PubMed ID: 789402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reverse passive haemagglutination (RPHA) test for detection of mycobacterial antigen in the cerebrospinal fluid for diagnosis of tubercular meningitis.
    Venkatesh K; Parija SC; Mahadevan S; Negi VS
    Indian J Tuberc; 2007 Jan; 54(1):41-8. PubMed ID: 17455423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HBV--status in professional blood donors in north India.
    Irshad M; Singh YN; Acharya SK
    Trop Gastroenterol; 1992; 13(3):112-4. PubMed ID: 1488797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determination of the hepatitis B virus surface antigen (HBsAg) by immunoenzyme analysis].
    Arakelov SA; Mikhaĭlov MI; Anan'ev VA; Stakhanova VM; Dzantiev BB
    Vopr Virusol; 1984; 29(3):319-23. PubMed ID: 6380111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of assay methods for hepatitis B surface (HBsAg) antigen and its antibody (anti-HBs) in viral hepatitis B (VHB)-HBsAg-positive.
    Mudrić V; Vuković B; Dimić E; Borota R
    Med Microbiol Immunol; 1978 Nov; 166(1-4):195-200. PubMed ID: 102913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of sic 'Third-Generation' tests for the detection of HBsAg.
    Reesink HW; Lafeber-Schut LJ; Aaij C; Reerink-Brongers EE
    Vox Sang; 1980 Aug; 39(2):61-72. PubMed ID: 7281596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of two rapid hepatitis B surface antigen detection tests for screening in a blood bank.
    Verstraeten T; Keya A
    East Afr Med J; 1997 Nov; 74(11):717-8. PubMed ID: 9557444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A study of potential risk of HBsAg negative with RPHA].
    Xiao YJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1991 May; 25(3):158-60. PubMed ID: 1914681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [IgM class antibodies against hepatitis A viruses in the differentiation of viral hepatitis].
    Zivanović-Marinković V; Stanković D; Parabucki S; Lazarov A; Marinković V; Krstić L; Letica Z
    Zb Vojnomed Akad; 1982; 24():24-7. PubMed ID: 6765185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of hemagglutination assays II. Enhancement in the sensitivity of an RPHA test for HBsAg.
    Horowitz B; Stryker M; Vandersande J; Lippin A; Woods KR
    Vox Sang; 1977 Dec; 33(6):335-45. PubMed ID: 930047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of turkey erythrocyte hemagglutination assay for the detection of hepatitis B antigen.
    Ramirez RI; Tiku ML; Ogra PL
    J Clin Microbiol; 1975 Feb; 1(2):185-7. PubMed ID: 1236871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B.
    Parkinson AJ; McMahon BJ; Hall D; Ritter D; Fitzgerald MA
    J Med Virol; 1990 Apr; 30(4):253-7. PubMed ID: 2196336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.